Skip to main content

Vulnerable Pakistanis to get priority for Chinese COVID-19 vaccine


By Masood Sattar Khan
(Pakistan News & Features Services)

China will provide a coronavirus vaccine candidate developed by Sinopharm, a unit of the China National Pharmaceutical Group, to Pakistan as part of a trial agreement.

The University of Karachi and Sinopharm are set to collaborate on vaccine trials and Pakistan will get vaccine doses sufficient to vaccinate one-fifth of its population. 

According to reports, the initial doses will be used to vaccinate the most vulnerable among the Pakistani population including the elderly, healthcare workers and people with medical conditions associated with serious cases of COVID-19.

Earlier in April, Sinopharm had invited the National Institute of Health (NIH), Islamabad, to collaborate in conducting clinical trials of its inactivated vaccine for COVID-19 in Pakistan. 

In a letter sent to NIH Executive Director Maj Gen Dr Aamer Ikram, the general manager of China Sinopharm International Corp, Li Can, had expressed the hope that a successful clinical trial in Pakistan will make it one of the first few countries for the launch of a Covid-19 vaccine. 

The NIH official was then reported to have stated that although clearances were needed for the purpose, the collaboration could be a great thing for Pakistan. Meanwhile, researchers have said that Sinopharm’s coronavirus vaccine candidate appeared to be safe and triggered antibody-based immune responses in early and mid-stage trials. 

The candidate has already moved into a late-stage trial, one of a handful of candidates being tested on several thousand people to see if they are effective enough to win regulatory approval. 

Sinopharm is testing the potential vaccine in the United Arab Emirates (UAE) in a Phase 3 trial expected to recruit 15,000 people, as China has too few new cases to be a useful trial site. 

The shot did not cause any serious side effects, according to a paper published in the Journal of the American Medical Association (JAMA) by scientists who are part of Sinopharm and other China-based disease control authorities and research institutes. The results were based on data from 320 healthy adults in Phase 1 and 2 trials. 

Sinopharm’s chairman told state media last month that a potential vaccine could be ready by the end of this year with Phase 3 testing expected to be completed in about three months. 

The novel coronavirus, which has killed more than 750,000 people globally, has prompted a race to develop a vaccine. More than 150 candidate vaccines are being developed and tested around the world. China is leading the development of at least eight vaccine candidates in different stages of clinical trials.
Labels:

Comments

Post a Comment

Popular posts from this blog

KDSP: Empowering Individuals with Down Syndrome in Karachi

The Karachi Down Syndrome Program (KDSP), a beacon of hope and support, is making significant strides in empowering individuals with Down syndrome in the city. Founded in March 2014 by a group of passionate parents and individuals, KDSP addresses the critical need for comprehensive resources and platforms for those with Down syndrome in Karachi. Bridging the Gap: A Mission of Advocacy and Inclusion KDSP operates as a non-profit organization with a clear mission: to advocate for the value, acceptance, and inclusion of individuals with Down syndrome. Recognizing the limited support and resources available locally, KDSP was established to provide a nurturing environment where individuals with Down syndrome can lead independent and fulfilling lives. A Lifelong Journey of Support Understanding the unique needs of individuals with Down syndrome and their families, KDSP offers unwavering support from the moment a family receives a diagnosis.  They embark on a journey with each family, pro...
Post a Comment
Read more

China’s top advisory body meets

By Masood Sattar Khan (Pakistan News & Features Services) The third annual session of the 13th National Committee of the Chinese People's Political Consultative Conference (CPPCC) opened on May 21, after being delayed for more than two months because of the COVID-19 pandemic. Much is expected of this year's session of China's top political advisers as the country's goal of building a moderately prosperous society in all aspects is expected to be realized by the end of this year, which is also the final year of the country's 13th Five-Year Plan (2016-20).  The CPPCC National Committee gathers the country's smartest minds from different walks of life.  Their ideas have contributed a great deal to what this country has achieved in its endeavors in poverty alleviation, in making progress in all fields for the realization of the goal of building China into a moderately prosperous country in all aspects. And so have their inputs into the fight against the novel co...
Post a Comment
Read more

Pakistan achieves another CPEC milestone

By Masood Sattar Khan (Pakistan News & Features Services)  With the launch of various projects in diverse fields under the auspices of the China Pakistan Economic Corridor (CPEC), Pakistan has achieved another milestone as new optical fibre cable from Khunjirab to Islamabad has been operationalized. According to the Chairman CPEC Authority, General Asim Saleem Bajwa, at the first stage the optical fibre cable has been operationalized from Khunjirab to Islamabad.  Through his twitter message, he further announced that in next phase the system will be laid from Islamabad to Karachi and from Islamabad Gwadar.  He pointed out that this step was a part of digital highway plan as well as it would be helpful to lay the foundation for digital and IT revolution, a project being done in conjunction with China. The operationalization of new optical fibre cable has been widely lauded by cross section of population, as after launching of different mega projec...
Post a Comment
Read more